Godavari Drugs Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 7.53 Cr
- Company Age 37 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 66.18 Cr
- Satisfied Charges ₹ 63.93 Cr
- Revenue Growth -0.68%
- Profit Growth -27.82%
- Ebitda -12.13%
- Net Worth 12.78%
- Total Assets 19.74%
About Godavari Drugs
Godavari Drugs Limited (GDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 02 December 1987 and has a history of 37 years and two months. Its registered office is in Hyderabad, Telangana, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530317.
The Corporate was formerly known as Godavari Drugs Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.53 Cr.
The company currently has active open charges totaling ₹66.18 Cr. The company has closed loans amounting to ₹63.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Godavari Drugs Limited India are Mohit Jaju as CFO and Venkatesh Achanta as Company Secretary. Ghanshyam Jaju, Mukund Kakani, Syed Hussain, and Four other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L24230TG1987PLC008016
- Company No.
008016
- Stock Symbol
BSE : 530317
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Dec 1987
- Date of AGM
12 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
What products or services does Godavari Drugs Limited offer?
Godavari Drugs Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Inorganic Salts, Ammonium Compound, Ammonium Chloride, Construction Chemical, Calcium Chloride, Potassium Salts, Monopotassium Phosphate.
Who are the key members and board of directors at Godavari Drugs?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukund Kakani  | Managing Director | 03-Dec-1987 | Current |
| Mohit Jaju | CFO | 16-May-2022 | Current |
| Venkatesh Achanta | Company Secretary | 29-May-2023 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ghanshyam Jaju | Director | 03-Dec-1987 | Current |
| Syed Hussain | Director | 27-Sep-2006 | Current |
| Mahendra Bhalerao | Director | 12-Nov-2022 | Current |
| Mohit Jaju | Whole-Time Director | 10-May-2012 | Current |
| Vimala Madon | Director | 27-Mar-2015 | Current |
| Dinesh Udpa | Additional Director | 16-Apr-2024 | Current |
Financial Performance of Godavari Drugs.
Godavari Drugs Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.68% decrease. The company also saw a substantial fall in profitability, with a 27.82% decrease in profit. The company's net worth Soared by an impressive increase of 12.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Godavari Drugs?
In 2023, Godavari Drugs had a promoter holding of 53.12% and a public holding of 46.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nichino India Private LimitedMahendra Bhalerao is a mutual person
Gameopedia Data Solutions Private LimitedVimala Madon is a mutual person
Sumarg Warehouse LlpGhanshyam Jaju is a mutual person
- Godavari Capital Private Limited
Ghanshyam Jaju and Mukund Kakani are mutual person
- Godavari Homes Ltd
Ghanshyam Jaju is a mutual person
Charges (Loans)
₹66.18 Cr
₹63.93 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 44.18 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 22.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹2.00 Cr | Open |
| 30 Mar 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹20.00 Cr | Open |
| 05 Jul 2018 | Yes Bank Limited | ₹44.18 Cr | Open |
| 10 Apr 2017 | Others | ₹3.70 Cr | Satisfied |
| 29 Nov 2014 | Others | ₹25.00 Cr | Satisfied |
How Many Employees Work at Godavari Drugs?
Godavari Drugs has a workforce of 92 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Godavari Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Godavari Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
